Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US Nursing Homes-Reference-Cited by-同舟云学术

Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US Nursing Homes

Published:2023-08-08 Issue:6 Volume:330 Page:561
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

McGarry Brian E.¹,Sommers Benjamin D.²,Wilcock Andrew D.³,Grabowski David C.³,Barnett Michael L.²

Affiliation:

1. Department of Medicine, University of Rochester, Rochester, New York

2. Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts

3. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts

Abstract

This study examines the use of COVID-19 antiviral treatments in US nursing homes and the facility characteristics associated with use of oral antivirals and monoclonal antibodies.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2807529/jama_mcgarry_2023_ld_230048_1691423440.68828.pdf

Reference6 articles.

1. A mobile unit overcomes the challenges to monoclonal antibody infusion for COVID-19 in skilled care facilities.;Tulledge-Scheitel;J Am Geriatr Soc,2021

2. Evolving real-world effectiveness of monoclonal antibodies for treatment of COVID-19: a cohort study.;Kip;Ann Intern Med,2023

3. Effectiveness of nirmatrelvir-ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system.;Lewnard;Lancet Infect Dis,2023

4. Centers for Medicare & Medicaid Services. COVID-19 nursing home data. Published 2023. Updated June 25, 2023. Accessed March 22, 2023. https://data.cms.gov/covid-19/covid-19-nursing-home-data

5. Department of Health and Human Services. Winter playbook for nursing homes and other long-term care facilities to manage COVID-19 and protect residents, staff, and visitors. Published 2022. Accessed May 17, 2023. https://www.whitehouse.gov/wp-content/uploads/2022/12/Winter-Playbook-for-Nursing-Homes-and-Other-Long-term-Care-Facilities-to-Manage-COVID-19-and-Protect-Residents-Staff-and-Visitors.pdf

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID‐19: An Analysis of the National COVID Cohort Collaborative (N3C);Pharmacoepidemiology and Drug Safety;2024-08

2. Clinical Outcomes After Admission of Patients With COVID-19 to Skilled Nursing Facilities;JAMA Internal Medicine;2024-07-01

3. Four Years And More Than 200,000 Deaths Later: Lessons Learned From The COVID-19 Pandemic In US Nursing Homes;Health Affairs;2024-07-01

4. Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US Adults;Infectious Diseases and Therapy;2024-06-23

5. Identifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation;Clinical Infectious Diseases;2024-06-12